Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis

Cancer Chemother Pharmacol. 2023 Jul;92(1):71-81. doi: 10.1007/s00280-023-04533-8. Epub 2023 Jun 5.

Abstract

Purpose: Tumor-promotive tumor-associated macrophages (TAMs) and the CXCL16/CXCR6 axis have been reported to be correlated with the limited efficacy of chemotherapy in ovarian cancer (OC). However, the role of TAM-secreted CXCL16 and the mechanism by which it affects the cisplatin (DDP) resistance of OC cells remain elusive.

Methods: We induced human THP-1 monocytes to differentiate into macrophages. Next, SKOV3 and TOV-112D cells were co-cultured with the macrophages, followed by incubation with increasing concentrations of DDP. The effects of CXCL16, CXCR6, and WTAP on the DDP resistance of OC cells were investigated using the CCK-8 assay, colony formation assay, flow cytometry, and TUNEL staining. CXCL16 concentrations were determined by ELISA. Quantitative real-time PCR and western blotting were used to examine related markers.

Results: Our results showed that after being co-cultured with TAMs, the DDP resistance of OC cells was significantly enhanced and their CXCL16 levels were elevated. Acquired DDP resistance was characterized by an increased IC50 value for DDP, the formation of cell colonies, and decreased levels of cell apoptosis, which were accompanied by reduced levels of caspase-3 and Bax expression, and increased levels of Bcl-2, PARP1, BRCA1, and BRCA2 expression. Either CXCL16 knockdown in TAMs or CXCR6 knockdown in OC cells suppressed the DDP resistance of OC cells that had been co-cultured with TAMs. Knockdown of CXCL16 affected m6A RNA methylation in OC cells, as reflected by decreased YTHDF1/WTAP expression and increased ALKBH5 expression. WTAP overexpression and knockdown promoted and suppressed the DDP resistance of OC cells, respectively.

Conclusion: Tumor-associated macrophages promote the cisplatin resistance of OC cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.

Keywords: CXCL16; DDP resistance; N6-methyladenosine; Ovarian cancer; Tumor-associated macrophage; WTAP.

MeSH terms

  • Cell Cycle Proteins
  • Cell Line, Tumor
  • Cell Proliferation
  • Cisplatin* / pharmacology
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Methylation
  • Ovarian Neoplasms* / drug therapy
  • RNA / pharmacology
  • RNA / therapeutic use
  • RNA Splicing Factors
  • Receptors, CXCR6
  • Tumor-Associated Macrophages

Substances

  • Cisplatin
  • RNA
  • CXCR6 protein, human
  • Receptors, CXCR6
  • WTAP protein, human
  • RNA Splicing Factors
  • Cell Cycle Proteins
  • CXCL16 protein, human